» Articles » PMID: 28424575

Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure

Overview
Journal Front Neurosci
Date 2017 Apr 21
PMID 28424575
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure (HF) is a complex syndrome representing the clinical endpoint of many cardiovascular diseases of different etiology. Given its prevalence, incidence and social impact, a better understanding of HF pathophysiology is paramount to implement more effective anti-HF therapies. Based on left ventricle (LV) performance, HF is currently classified as follows: (1) with reduced ejection fraction (HFrEF); (2) with mid-range EF (HFmrEF); and (3) with preserved EF (HFpEF). A central tenet of HFrEF pathophysiology is adrenergic hyperactivity, featuring increased sympathetic nerve discharge and a progressive loss of rhythmical sympathetic oscillations. The role of reflex mechanisms in sustaining adrenergic abnormalities during HFrEF is increasingly well appreciated and delineated. However, the same cannot be said for patients affected by HFpEF or HFmrEF, whom also present with autonomic dysfunction. Neural mechanisms of cardiovascular regulation act as "controller units," detecting and adjusting for changes in arterial blood pressure, blood volume, and arterial concentrations of oxygen, carbon dioxide and pH, as well as for humoral factors eventually released after myocardial (or other tissue) ischemia. They do so on a beat-to-beat basis. The central dynamic integration of all these afferent signals ensures homeostasis, at rest and during states of physiological or pathophysiological stress. Thus, the net result of information gathered by each controller unit is transmitted by the autonomic branch using two different codes: and of sympathetic discharges. The main scope of the present article is to (i) review the key neural mechanisms involved in cardiovascular regulation; (ii) discuss how their dysfunction accounts for the hyperadrenergic state present in certain forms of HF; and (iii) summarize how sympathetic efferent traffic reveal central integration among autonomic mechanisms under physiological and pathological conditions, with a special emphasis on pathophysiological characteristics of HF.

Citing Articles

Low-level auricular vagus nerve stimulation lowers blood pressure and heart rate in paroxysmal atrial fibrillation patients: a self-controlled study.

Jiang Y, Su D, Xiao J, Cheng W, Hou Y, Zhang Y Front Neurosci. 2025; 19:1525027.

PMID: 39944888 PMC: 11813895. DOI: 10.3389/fnins.2025.1525027.


β-adrenergic regulation of Ca signaling in heart cells.

Yang B, Wang S, Yang H Biophys Rep. 2024; 10(5):274-282.

PMID: 39539286 PMC: 11554573. DOI: 10.52601/bpr.2024.240906.


The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF.

Triposkiadis F, Briasoulis A, Sarafidis P, Magouliotis D, Athanasiou T, Paraskevaidis I J Clin Med. 2023; 12(20).

PMID: 37892623 PMC: 10607346. DOI: 10.3390/jcm12206486.


Altered Heart Rate Turbulence and Variability Parameters Predict 1-Year Mortality in Heart Failure with Preserved Ejection Fraction.

Ksela J, Rupert L, Djordjevic A, Antonic M, Avbelj V, Jug B J Cardiovasc Dev Dis. 2022; 9(7).

PMID: 35877575 PMC: 9321795. DOI: 10.3390/jcdd9070213.


Cardiac Spinal Afferent Denervation Attenuates Renal Dysfunction in Rats With Cardiorenal Syndrome Type 2.

Xia Z, Vellichirammal N, Han L, Gao L, Boesen E, Schiller A JACC Basic Transl Sci. 2022; 7(6):582-596.

PMID: 35818505 PMC: 9270585. DOI: 10.1016/j.jacbts.2022.02.008.


References
1.
Montano N, Ruscone T, Porta A, Lombardi F, Pagani M, Malliani A . Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation. 1994; 90(4):1826-31. DOI: 10.1161/01.cir.90.4.1826. View

2.
De Luca L, Fonarow G, Adams Jr K, Mebazaa A, Tavazzi L, Swedberg K . Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev. 2007; 12(2):97-104. DOI: 10.1007/s10741-007-9011-8. View

3.
Lymperopoulos A, Rengo G, Koch W . Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013; 113(6):739-53. PMC: 3843360. DOI: 10.1161/CIRCRESAHA.113.300308. View

4.
Di Vanna A, Braga A, Laterza M, Ueno L, Rondon M, Barretto A . Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure. Am J Physiol Heart Circ Physiol. 2007; 293(1):H846-52. DOI: 10.1152/ajpheart.00156.2007. View

5.
Lavie L . Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain. Sleep Med Rev. 2014; 20:27-45. DOI: 10.1016/j.smrv.2014.07.003. View